California Cancer Research Program- Cycle I Awards

	California Cancer Research Program
	Awards

Funded projects may be listed under multiple organ sites, depending on the nature of the research funded.

Principal Investigator

Amount

Project Title

Bladder Cancer

Allan H. Smith, M.D., Ph.D. University of California, Berkeley Epidemiology Investigator-Initiated Award	$638,803	California Arsenic Methylation Study [Abstract]
Cervical Cancer

Kathleen L. McGuire, Ph.D. San Diego State University General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$165,000	Mimicking Natural Products to Develop Novel Cancer Drugs [Abstract]
Robert J. Melton, M.D., M.P.H. Monterey County Health Department Marilyn A. Winkleby, Ph.D. Stanford University Prevention Community-Initiated Research Collaboration Award	$96,800	IMPACTO II: The Monterey Co. Hispanic B.R.F.S. Study [Abstract]
Childhood Cancer

James R. Feramisco, Ph.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$193,567	Molecular Basis of the Childhood Tumor, Rhabdomyosarcoma [Abstract]
Jan M. Van Tornout, M.D. Childrens Hospital Los Angeles Epidemiology Pilot and Feasibility Study Award	$199,321	Steroid Receptor Genes and Ewing's Sarcoma of Bone in Children [Abstract]
Colorectal Cancer

C. Richard Boland, M.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$982,671	Chromosomal Instability in Colorectal Cancer [Abstract]
Stavros G. Demos, Ph.D. Lawrence Livermore National Laboratory Clinical Research Investigator-Initiated Award	$1,089,795	Endoscopic Subsurface Optical Imaging for Cancer Detection [Abstract]
Diane M. Harris, Ph.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$302,610	Nutrient/Gene Interactions in Apc-min, a Mouse Model of Colon Cancer [Abstract]
Young S. Kim, M.D. Northern California Institute for Research and Education, Inc. Clinical Research Investigator-Initiated Award	$970,960	Chemopreventive Effect of Balsalazide on Colorectal Polyps [Abstract]
Joseph P. Konopelski, Ph.D. University of California, Santa Cruz General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$527,175	Synthesis of Novel Anticancer Agents From Marine Sources [Abstract]
Sergei R. Malkhosyan, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$728,811	DNA Mismatch Repair Defects and Mutator Phenotype in Cancer [Abstract]
Sergei R. Malkhosyan, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$251,045	Therapy of the Cancer of the Microsatellite Mutator Phenotype [Abstract]
Robert J. Melton, M.D., M.P.H. Monterey County Health Department Marilyn A. Winkleby, Ph.D. Stanford University Prevention Community-Initiated Research Collaboration Award	$96,800	IMPACTO II: The Monterey Co. Hispanic B.R.F.S. Study [Abstract]
Paul T. Williams, Ph.D. Ernest Orlando Lawrence Berkeley National Laboratory Prevention Investigator-Initiated Award	$1,218,746	Internet Study and Resource for Studing Diet and Activity [Abstract]
Gender-Specific Cancers

Wendy Max, Ph.D. University of California, San Francisco Prevention Investigator-Initiated Award	$478,590	The Costs of Gender-Specific Cancers in California [Abstract]
Wanda F. Reynolds, Ph.D. Sidney Kimmel Cancer Center General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$259,116	Myeloperoxidase as a Gender-Specific Risk Factor for Cancer [Abstract]
Cheryl L. Rock, Ph.D., R.D. University of California, San Diego Prevention Investigator-Initiated Award	$763,445	Measuring Dietary Change and Its Effect on Hormone Levels [Abstract]
Tammy O. Tengs, Sc.D. University of California, Irvine Prevention Investigator-Initiated Award	$918,053	Cost-effectiveness of Cancer Prevention and Control [Abstract]
General Cancer

Nuria Assa-Munt, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$984,506	NMR Structure of BIR-Biochemical Inhibitor of Apoptosis and of Survivin [Abstract]
Roymarie Ballester, Ph.D. University of California, Santa Barbara General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$132,440	Identification of Wsc Homologs in Animal Cells [Abstract]
David A. Calderwood, Ph.D. The Scripps Research Institute General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$349,075	The Function of PEA-15, a Gene Overexpressed in Cancer [Abstract]
Regino Chavez Prevention Diet and Behavior Change TRFA	$55,000	What Will I Fix to Eat: Exploring Meal Planning and Food Choices [Abstract]
Ofelia V. Dirige, Dr. P.H., R.D. Kalusugan Community Services Cheryl L. Rock, Ph.D., R.D. University of California, San Diego Prevention Community-Initiated Research Collaboration Award	$96,800	Cancer Prevention for San Diego Filipino Americans [Abstract]
Kathryn R. Ely, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$257,400	Molecular Basis of Signal Transduction Mediated by pl30Cas [Abstract]
Christopher Gardner, Ph.D. University of California, Davis Prevention Diet and Behavior Change TRFA	$1,400,000	Center for Advanced Studies in Nutrition & Social Marketing [Abstract]
Gourisankar Ghosh, Ph.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$299,486	Structure/Function Studies of Oncogenic Proteins vRel and cRel [Abstract]
Jiahuai Han, Ph.D. The Scripps Research Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$740,976	Signaling Mechanisms of Radiation-Induced Cancer Cell Death [Abstract]
Esther P. Hill, Ph.D. Juarez and Associates, Inc. Prevention Diet and Behavior Change TRFA	$1,313,000	Restaurant Nutrition Program: Implementation and Evaluation [Abstract]
Luisa Iruela-Arispe, Ph.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$201,636	Anti-Angiogenic Activity of METH-1 in Tumors [Abstract]
Eloise Jenks, M.Ed., R.D. Public Health Foundation Enterprises Gail G. Harrison, Ph.D., R.D. University of California, Los Angeles Prevention Community-Initiated Research Collaboration Award	$71,790	Dietary Quality and Food Security Among WIC Participants [Abstract]
Michael Karin, Ph.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$1,323,409	Inhibition of Survival Responses as an Anti-cancer Strategy [Abstract]
Joel D. Killen, Ph.D. Stanford University Prevention Pilot and Feasibility Study Award	$204,599	Environmental Influences on Children's Food Intake [Abstract]
Jiing-Dwan Lee, Ph.D. The Scripps Research Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$773,231	The Role of BMK1/ERK5 Pathway in Cancer Cell Growth [Abstract]
Chih-Jian (Jason) Lih, Ph.D. Stanford University General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$306,900	Identification of Genes Involved in Chemotherapy Resistance [Abstract]
Thomas Quertermous, M.D. Stanford University General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$1,229,262	An Embryonic Angiogenic Factor is a Target for Tumor Therapy [Abstract]
Kathleen M. Sakamoto, M.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$609,344	Cell Cycle Control and Cancer [Abstract]
Tammy O. Tengs, Sc.D. University of California, Irvine Prevention Investigator-Initiated Award	$918,053	Cost-effectiveness of Cancer Prevention and Control [Abstract]
Myeloma

Peter L. Greenberg, M.D. Stanford University General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$144,474	Gene Expression in Myelodysplastic Syndromes [Abstract]
Ovarian Cancer

Nancy K. Amy, Ph.D. University of California, Berkeley Prevention Pilot and Feasibility Study Award	$218,398	Ovarian Cancer in Large Women: Reducing Barriers to Care [Abstract]
Robert C. Brasch, M.D. University of California, San Francisco Clinical Research Investigator-Initiated Award	$711,284	MRI Grading of Ovarian Cancer Microvessels [Abstract]
Christina L. Chang, Ph.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$199,002	Molecular Mechanism of NDP Kinase A in Tumor Metastasis [Abstract]
Stanley N. Cohen, M.D. Stanford University General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$1,193,309	Genes that Suppress Metatasis of Human Ovarian Cancers [Abstract]
Rosemary D. Cress, Dr.P.H. Public Health Institute Epidemiology Population-Based Epidemiology TRFA	$327,424	Quality of Care for Women with Ovarian Cancer [Abstract]
Edward J. Goetzl, M.D. University of California, San Francisco General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$189,171	Lysophospholipid Receptors and Effects in Ovarian Cancer [Abstract]
Shi Huang, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$1,008,487	The p53 Pathway in Ovarian Cancer [Abstract]
Joseph P. Konopelski, Ph.D. University of California, Santa Cruz General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$527,175	Synthesis of Novel Anticancer Agents From Marine Sources [Abstract]
Kathleen L. McGuire, Ph.D. San Diego State University General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$165,000	Mimicking Natural Products to Develop Novel Cancer Drugs [Abstract]
Paul K. Mills, Ph.D. Public Health Institute Epidemiology Population-Based Epidemiology TRFA	$926,325	Triazine Herbicides and Ovarian Cancer Risk [Abstract]
Nicholas J. Rampino, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$779,887	Select Microsatellite Mutations in Key Cancer Genes [Abstract]
Branimir I. Sikic, M.D. Stanford University General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$741,901	Genomic Profiling of Ovarian Cancers [Abstract]
Virginia Urquidi, Ph.D. University of California, San Diego Clinical Research Pilot and Feasibility Study Award	$195,824	Stage-specific Gene Expression in Ovarian Cancer Progression [Abstract]
Henry F. VanBrocklin, Ph.D. Ernest Orlando Lawrence Berkeley National Laboratory Clinical Research Pilot and Feasibility Study Award	$214,658	Choline-Based Imaging Agents for Non-Invasive Tumor Detection [Abstract]
Geoffrey M. Wahl, Ph.D. The Salk Institute for Biological Studies General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$990,140	Novel Treatment Targeting Cancer Cell Genetic Instability [Abstract]
John Yu, M.D., Ph.D. The Scripps Research Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$740,977	Clinical Relevance of Thioredoxin in Ovarian Cancer [Abstract]
Pancreatic Cancer

Carson D. Liu, Ph.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$294,710	Synthetic Gut Hormones in the Treatment of Pancreatic Cancer [Abstract]
Prostate Cancer

William J. Aronson, M.D. Brentwood Biomedical Research Institute Prevention Pilot and Feasibility Study Award	$145,200	Soy Protein and Low Fat Diet for Prostate Cancer Treatment [Abstract]
James J. Beaumont, Ph.D., M.S.P.H. University of California, Davis Epidemiology Pilot and Feasibility Study Award	$122,104	Bias from Loss to Interview in Prostate Cancer Epidemiology [Abstract]
Leonard F. Bjeldanes, Ph.D., BCh University of California, Berkeley Prevention Pilot and Feasibility Study Award	$191,118	Control of Prostate Tumor Cell Growth by Dietary Indoles [Abstract]
Robert A. Bok, M.D., Ph.D. University of California, San Francisco General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$197,991	The Role of Proteases in Prostate Cancer Progression [Abstract]
Sharan L. Campleman, Ph.D., M.P.H. Public Health Institute Prevention Population-Based Epidemiology TRFA	$266,715	Prostate Cancer in Rural California: Diagnosis and Treatment [Abstract]
Christina L. Chang, Ph.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$199,002	Molecular Mechanism of NDP Kinase A in Tumor Metastasis [Abstract]
Rowan T. Chlebowski, M.D., Ph.D. Harbor - UCLA Research and Education Institute Clinical Research Pilot and Feasibility Study Award	$179,201	Androgen Ablation and Co-Morbid Disease in Prostate Cancer [Abstract]
Richard J. Cote, M.D. University of Southern California Clinical Research Investigator-Initiated Award	$690,842	Detection and Mechanism of Occult Metastases in Prostate Carcinoma [Abstract]
Stavros G. Demos, Ph.D. Lawrence Livermore National Laboratory Clinical Research Investigator-Initiated Award	$1,089,795	Endoscopic Subsurface Optical Imaging for Cancer Detection [Abstract]
Graeme J. Dougherty, Ph.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$169,927	Combining Radiation Therapy with Cancer Gene Immunotherapy [Abstract]
Steven M. Dubinett, M.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$201,630	Genetic Immunotherapy for Prostate Cancer [Abstract]
Faye A. Eggerding, M.D., Ph.D. Huntington Medical Research Institute Clinical Research Pilot and Feasibility Study Award	$143,846	Molecular Markers of Prostate Cancer Risk [Abstract]
Christopher P. Evans, M.D. University of California, Davis General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$278,005	Targeting Androgen-Regulated Transcription in Prostate Cancer [Abstract]
Ruth A. Gjerset, Ph.D. Sidney Kimmel Cancer Center General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$258,842	A Novel Tumor Supressor Approach to Cancer Therapy [Abstract]
Lee Goodglick, Ph.D. University of California, Los Angeles Clinical Research New Investigator Award	$302,610	Pathway for Prostate Cancer Resistance to an Anticancer Agent [Abstract]
Sue A. Ingles, M.A., Dr.P.H. University of Southern California Epidemiology Investigator-Initiated Award	$1,499,943	Advanced Prostate Cancer - Risk Factors in African-Americans [Abstract]
Esther M. John, Ph.D. Northern California Cancer Center Epidemiology Investigator-Initiated Award	$1,002,506	Lifestyle Factors and Risk of Advanced Prostate Cancer [Abstract]
Lawrence W. Jones, M.D. Huntington Memorial Hospital Clinical Research Investigator-Initiated Award	$441,918	Rhodamine-123: Innovative Treatment for Prostate Cancer [Abstract]
Hsing-Jien Kung, Ph.D. University of California, Davis General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$551,948	Kinases as Prostate Cancer Markers and Regulators [Abstract]
Marion M. Lee, Ph.D. University of California, San Francisco Psychosocial/Cultural Aspects Investigator-Initiated Award	$799,952	Complementary Therapy Use and Quality of Life in Men with Prostate Cancer [Abstract]
Mark S. Litwin, M.D., M.P.H. University of California, Los Angeles Psychosocial/Cultural Aspects Investigator-Initiated Award	$648,042	Quality of Life in Men with Early Stage Prostate Cancer [Abstract]
Sergei R. Malkhosyan, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$251,045	Therapy of the Cancer of the Microsatellite Mutator Phenotype [Abstract]
Paul K. Mills, Ph.D. Public Health Institute Epidemiology Population-Based Epidemiology TRFA	$410,469	Prostate and Testicular Cancer in Farm Workers [Abstract]
Brian J. Murphy, Ph.D. SRI International General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$246,175	Heme Oxygenase Inhibition for Prostate Tumor Treatment [Abstract]
Jacqueline O'Connor, Ph.D. University of California, Davis Psychosocial/Cultural Aspects New Investigator Award	$288,431	Benign Prostate Biopsy: Cancer-Relevant Behavioral Sequelae [Abstract]
Shen Pang, Ph.D. University of California, Los Angeles Clinical Research Investigator-Initiated Award	$620,328	A Prostate-Specific Lentiviral Vector for Gene Therapy [Abstract]
Donna M. Peehl, Ph.D. Stanford University Clinical Research Investigator-Initiated Award	$1,426,528	Vitamin D and Prostate Cancer: Risk, Prevention and Therapy [Abstract]
Francisco J. Piedrafita, Ph.D. Sidney Kimmel Cancer Center General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$253,732	Apoptotic Retinoids and JNK Activity in Prostate Cancer [Abstract]
Nicholas J. Rampino, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$779,887	Select Microsatellite Mutations in Key Cancer Genes [Abstract]
Juergen K.V. Reichardt, Ph.D. University of Southern California General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$1,338,297	Benign Prostatic Hypertrophy (BPH) and the SR.D.5A2 Gene [Abstract]
Michael G. Rosenfeld, M.D. University of California, San Diego General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$1,159,065	Roles of Nuclear Receptor Coregulators in Prostate Cancer [Abstract]
Georgia R. Sadler, M.B.A., Ph.D. University of California, San Diego Psychosocial/Cultural Aspects Investigator-Initiated Award	$734,872	Problem Solving Therapy for Prostate Cancer Caregivers [Abstract]
Eli E. Sercarz, Ph.D. La Jolla Institute for Allergy & Immunology General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$755,370	Targeting the T Cell Repertoire Against Tumor-Specific Determinants [Abstract]
Atsuko Shibata, M.D., Ph.D., M.P.H. Stanford University Clinical Research Pilot and Feasibility Study Award	$196,499	Genetic Markers and Prostate Cancer Prognosis [Abstract]
Eila C. Skinner, M.D. University of Southern California Clinical Research Investigator-Initiated Award	$1,217,810	Effect of Selenium on Prostate Tissue of High Risk Men [Abstract]
Timothy D. Solberg, Ph.D. University of California, Los Angeles Clinical Research New Investigator Award	$273,119	A Novel Approach to Intensity Modulated Radiotherapy [Abstract]
Andrew A. Stolz, M.D. University of Southern California General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$215,983	Molecular Epidemiology of 3a-HSD in Prostate Cancer [Abstract]
Shinichi Takayama, Ph.D. The Burnham Institute General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$257,302	BAG-Family Proteins in Prostate Cancer [Abstract]
Michael A. Thomas, Ph.D. University of California, Los Angeles Clinical Research Pilot and Feasibility Study Award	$189,039	Diffusion-Weighted MRI and MR Spectroscopy of Prostate Tumors [Abstract]
Henry F. VanBrocklin, Ph.D. Ernest Orlando Lawrence Berkeley National Laboratory Clinical Research Pilot and Feasibility Study Award	$214,658	Choline-Based Imaging Agents for Non-Invasive Tumor Detection [Abstract]
Geoffrey M. Wahl, Ph.D. The Salk Institute for Biological Studies General Cancer Biology, Etiology, and Pathogenesis Investigator-Initiated Award	$990,140	Novel Treatment Targeting Cancer Cell Genetic Instability [Abstract]
Ameae M. Walker, Ph.D. University of California, Riverside General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$191,884	Prostate Cancer Treatment with Prolactin Receptor Antagonist [Abstract]
Matthew D. Weitzman, Ph.D. The Salk Institute for Biological Studies General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$242,220	Viral Vectors for Gene Therapy of Prostate Cancer [Abstract]
Alice S. Whittemore, Ph.D., M.A. Stanford University Epidemiology Investigator-Initiated Award	$279,459	Prostate Cancer Survival in a Multi-ethnic Cohort [Abstract]
Paul T. Williams, Ph.D. Ernest Orlando Lawrence Berkeley National Laboratory Prevention Investigator-Initiated Award	$1,218,746	Internet Study and Resource for Studing Diet and Activity [Abstract]
Lily Wu, M.D., Ph.D. University of California, Los Angeles General Cancer Biology, Etiology, and Pathogenesis New Investigator Award	$301,258	Targeted Prostate Cancer Gene Therapy Using Potent Herpes Thymidine Kinase Variants Delivered by Adenovectors [Abstract]
Paul O. Zamora , Ph.D. Innerdyne, Inc. Robert Lull, M.D. University of California, San Francisco Clinical Research Community-Initiated Research Collaboration Award	$87,000	Absorbable Brachytherapy Devices for Cancer Therapy [Abstract]
Skin Cancer

Romaine E. Saxton, Ph.D. University of California, Los Angeles Clinical Research Pilot and Feasibility Study Award	$199,641	Laser and Hypericin Phototherapy for Squamous Cell Carcinoma [Abstract]
Edward T. Wei, Ph.D. University of California, Berkeley General Cancer Biology, Etiology, and Pathogenesis Pilot and Feasibility Study Award	$196,665	Melanocortin Receptor Antagonists as Adjunct Therapy for Melanoma [Abstract]
Testicular Cancer

Victoria K. Cortessis, Ph.D. University of Southern California Epidemiology Investigator-Initiated Award	$1,262,719	Genetic Epidemiology of Testicular Cancer and Cryptorchidism [Abstract]
Paul B. English, Ph.D., M.P.H. Impact Assessment, Inc. Epidemiology Investigator-Initiated Award	$751,628	Exploring Perinatal Risk Factors for Testicular Cancer [Abstract]
Paul K. Mills, Ph.D. Public Health Institute Epidemiology Population-Based Epidemiology TRFA	$410,469	Prostate and Testicular Cancer in Farm Workers [Abstract]

California Cancer Research Program
(916) 449-5550
E-mail crp@dhs.ca.gov